Frexalimab | m-entrepreneurship.com

Product Name :
Frexalimab

Search keywords :
Frexalimab

drugId :
null

Target Vo:
CD40 ligand

Target Vo Short Name :
CD40L

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunext Inc

Active Company_Name :
Royalty Pharma PLC

Active Indication_Name:
Multiple Sclerosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MSR1 Antibody
Atg12 Antibody
HIF1 alpha Antibody: HIF1 alpha Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 93 kDa, targeting to HIF1 alpha. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts